CCM
HALO icon

CAAS Capital Management’s Halozyme HALO Stock Holding History

CAAS Capital Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$300K Buy
+4,700
New +$273K 0.03% 321

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CAAS Capital Management's HALO Position: Q1 2025 in Review

CAAS Capital Management opened a new position in Halozyme (HALO) in Q1 2025: 4,700 shares worth $300K. The stake represents 0.03% of the portfolio and ranks #321 among its holdings.

550 funds tracked by Wall St. Rank hold HALO as of Q1 2025.

  • CAAS Capital Management held 4,700 shares of Halozyme worth $300K as of Q1 2025.
  • Halozyme was a new CAAS Capital Management position in Q1 2025.
  • Halozyme made up 0.03% of CAAS Capital Management's portfolio in Q1 2025, its #321 holding.
  • 550 funds tracked by Wall St. Rank held Halozyme as of Q1 2025.

Based on CAAS Capital Management's 13F filing for Q1 2025, filed 1 May 2025.